These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24182605)

  • 1. Generalizability of cost-utility analyses across countries and settings.
    Ginsberg GM
    Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):845-52. PubMed ID: 24182605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost/DALY averted in a small hospital in Sierra Leone: what is the relative contribution of different services?
    Gosselin RA; Thind A; Bellardinelli A
    World J Surg; 2006 Apr; 30(4):505-11. PubMed ID: 16528459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we better prioritize resources for cost-utility research?
    Neumann PJ; Rosen AB; Greenberg D; Olchanski NV; Pande R; Chapman RH; Stone PW; Ondategui-Parra S; Nadai J; Siegel JE; Weinstein MC
    Med Decis Making; 2005; 25(4):429-36. PubMed ID: 16061895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analyses of drug therapies in breast cancer: a systematic review.
    Nerich V; Saing S; Gamper EM; Kemmler G; Daval F; Pivot X; Holzner B
    Breast Cancer Res Treat; 2016 Oct; 159(3):407-24. PubMed ID: 27572551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.
    Rutstein SE; Price JT; Rosenberg NE; Rennie SM; Biddle AK; Miller WC
    Glob Public Health; 2017 Oct; 12(10):1269-1281. PubMed ID: 27141969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do we evaluate the economics of health care?
    Kumar S; Williams AC; Sandy JR
    Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economics in developing countries.
    Abel-Smith B
    J Trop Med Hyg; 1989 Aug; 92(4):229-41. PubMed ID: 2503621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost Effectiveness of Childhood Cochlear Implantation and Deaf Education in Nicaragua: A Disability Adjusted Life Year Model.
    Saunders JE; Barrs DM; Gong W; Wilson BS; Mojica K; Tucci DL
    Otol Neurotol; 2015 Sep; 36(8):1349-56. PubMed ID: 26171672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted.
    Neumann PJ; Thorat T; Zhong Y; Anderson J; Farquhar M; Salem M; Sandberg E; Saret CJ; Wilkinson C; Cohen JT
    PLoS One; 2016; 11(12):e0168512. PubMed ID: 28005986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A strategic approach to the unfinished fortification agenda: feasibility, costs, and cost-effectiveness analysis of fortification programs in 48 countries.
    Fiedler JL; Macdonald B
    Food Nutr Bull; 2009 Dec; 30(4):283-316. PubMed ID: 20496620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex interface between economy and healthcare: An introductory overview for clinicians.
    Ottolini FL; Buggio L; Somigliana E; Vercellini P
    Eur J Intern Med; 2016 Dec; 36():1-6. PubMed ID: 27577606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of ocular interventions.
    Busbee BG; Brown GC; Brown MM
    Curr Opin Ophthalmol; 2003 Jun; 14(3):132-8. PubMed ID: 12777931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic evaluation in health care].
    Zechmeister I; Radlberger P
    Wien Med Wochenschr; 2009; 159(5-6):160-8. PubMed ID: 19343294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropharmacoeconomics].
    Chiu HC
    Acta Neurol Taiwan; 2004 Jun; 13(2):87-96. PubMed ID: 15478681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US.
    Ladapo JA; Neumann PJ; Keren R; Prosser LA
    Pharmacoeconomics; 2007; 25(10):817-28. PubMed ID: 17887804
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.